MedPath

Guangdong GD Kongming Biotech LLC.

🇨🇳China
Ownership
Private
Established
2018-03-12
Employees
-
Market Cap
-
Website
https://www.gdkongming.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

Phase 1
Withdrawn
Conditions
Advanced Hepatocellular Carcinoma
First Posted Date
2022-11-28
Last Posted Date
2023-01-18
Lead Sponsor
Guangdong GD Kongming Biotech LLC
Registration Number
NCT05628545
Locations
🇨🇳

Zhuhai People'S Hospital, Zhuhai, Guangdong, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.